[1]
N. Ntertsos, “Clinical Approach to Immunotherapy-induced Type 1 Diabetes Mellitus: A Case of Pembrolizumab Associated Insulin-dependent Diabetes in a Patient with NSCLC”, J Pulmonol Respir Res, vol. 7, no. 2, pp. 024–027, Sep. 2023.